Home > Boards > US Listed > Miscellaneous > CryoPort Inc. (CYRX)

All in all, it was a good quarter

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
hyperopia Member Profile
 
Followed By 1
Posts 214
Boards Moderated 0
Alias Born 09/10/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 5:21:27 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/20/2019 5:30:08 PM
Cryoport Announces Pricing of Public Offering of Common Stock PR Newswire (US) - 6/19/2019 9:02:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/19/2019 5:11:53 PM
Cryoport Announces Proposed Public Offering of Common Stock PR Newswire (US) - 6/19/2019 4:03:00 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/14/2019 5:06:52 PM
CalAmp Announces Research Collaboration with Cryoport to Develop Next Generation Condition Monitoring System PR Newswire (US) - 5/16/2019 8:00:00 AM
Cryoport Expands into Biostorage through the Acquisition of Cryogene PR Newswire (US) - 5/14/2019 5:22:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2019 5:12:37 PM
Cryoport to Host Workshop at 14th Annual World Advanced Therapies & Regenerative Medicine Congress on Wednesday, May 15th PR Newswire (US) - 5/9/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 7:54:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 7:52:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 7:49:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2019 4:15:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2019 4:05:46 PM
Cryoport Revenue Grows 65% for First Quarter 2019 PR Newswire (US) - 5/2/2019 4:05:00 PM
Cryoport to Report First Quarter 2019 Financial Results on May 2nd, 2019 PR Newswire (US) - 4/25/2019 8:30:00 AM
Celularity Selects Cryoport's Temperature Controlled Logistics Solutions PR Newswire (US) - 4/11/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/10/2019 3:30:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/4/2019 6:09:09 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/3/2019 5:25:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2019 7:21:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2019 7:17:25 PM
Market Trends Toward New Normal in Verizon Communications, Digital Turbine, Vericel, Capstead Mortgage, Paratek Pharmaceutica... GlobeNewswire Inc. - 4/1/2019 8:10:00 AM
Biokin Pharmaceutical Selects Cryoport's Temperature-Controlled Solutions for its Pending Phase I and Phase II trials PR Newswire (US) - 3/28/2019 8:46:00 AM
hyperopia   Friday, 03/08/19 12:30:19 PM
Re: CYRXorbust post# 11582
Post # of 11885 


All in all, it was a good quarter and a solid year. 40 net new trials were added this quarter, and 120 clinical trials were added for the year, for an impressive total of 357. Cryoport said they held nearly 40% of the clinical trial market in the Regenerative Medicine space, which is a good thing, because clinical trials looks to be where the bulk of their revenues will come from for the next year or two.

So, 4 MAA's were filed in Europe and 2 BLA's were filed in the United States during 2018, and we found out from some good questioning (from the B. Riley FBR analyst, Andrew D’Silva) that 5 are Cryoport clients. This is one of the few things that management offered guidance on last year and they were accurate on that. But so far, no news on when to expect approvals or when they will begin commercial sales. They now anticipate six additional BLA and MAA submissions from Cryoport’s clients in 2019. Novartis expects to increase Kymriah revenues fourfold, and Gilead is projecting sales of Yescarta to double this year, but it still looks to be a slow ramp for commercial revenues.

And contrary to a belief held by a certain poster here, (cough cough) the company said it is actively pursuing potential acquisitions. Shelton said “we'll look at software companies, we'll look at components of manufacturing that could provide strategic advantage. We'll also look at adjacencies and we talked about some of those in the past, like storage and like, again, software and other services that we think fit with our Company. So, we definitely are looking at them, but we have yet to pull the trigger.”

Don't worry CB, I think you will still have another chance to sell in the teens.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist